noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Armanino Foods of Distinction Inc.

Armanino Foods Appoints Andrew Leonard as Chief Financial Officer
CNS Pharmaceuticals Inc.

Management Change/Compensation (Form 8-K)
NJCPA - New Jersey Society of[...]

NJCPA Raises More Than $30,000 for Community FoodBank of New Jersey

Healthcare

Axogen Inc.

12/17/2025 | Press release | Distributed by Public on 12/17/2025 06:02

Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference

Download as PDF December 17, 2025

ALACHUA, Fla. and TAMPA, Fla., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that the company will be participating in the upcoming J.P. Morgan 2026 Healthcare Conference.

Axogen's management is scheduled to present on Thursday, January 15, 2026, at 10:30 AM Pacific Standard Time. Interested parties may access a live audio webcast of the presentation by visiting the "Investors" section of the company's website at ir.axogeninc.com.

About Axogen

Axogen (NASDAQ: AXGN) is focused on the science, development and commercialization of technologies for peripheral nerve repair. With a mission to make nerve repair the expected standard of care, Axogen advances the field through research, education, and collaboration with surgeons and healthcare providers across a global network.

Axogen's product portfolio includes Avance® (acellular nerve allograft-arwx), Axoguard Nerve Connector®, Axoguard Nerve Protector®, Axoguard HA+ Nerve Protector™, Axoguard Nerve Cap®, and Avive+ Soft Tissue Matrix™. The Axogen portfolio of products is available in the United States, Canada, Germany, the United Kingdom, Spain and several other countries.

For more information, visit https://www.axogeninc.com.

Contact:
Axogen, Inc.
[email protected]

Source: Axogen, Inc.

Released December 17, 2025

Axogen Inc. published this content on December 17, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on December 17, 2025 at 12:02 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]